Dilys J Bart, MD
Ophthalmology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
- Since medical school
- 33 years
- University of California, San Francisco School of Medicine, 1993
Offices
1 location
Looking this up.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bart’s office at (415) 751-7700 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$65,480
Medicare paid this office $65,480 for 319 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 268 | $41,901 | $106 |
| New patient complete exam of visual system | 55 | $6,322 | $115 |
| Established patient problem focused exam of visual system | 58 | $6,279 | $82 |
| Exam of visual field with extended testing | 81 | $5,007 | $58 |
| Photography of the retina | 72 | $2,336 | $32 |
See all 6 services
| Established patient complete exam of visual system | 268 | $41,901 | $106 |
| New patient complete exam of visual system | 55 | $6,322 | $115 |
| Established patient problem focused exam of visual system | 58 | $6,279 | $82 |
| Exam of visual field with extended testing | 81 | $5,007 | $58 |
| Photography of the retina | 72 | $2,336 | $32 |
| Ultrasound scan of cornea to determine thickness | 17 | $135 | $8 |
Procedures Medicare counted
| Cataract surgery | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of cataract with insertion of prosthetic lens | 16 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
319 Original Medicare patients in 2024. Average age 76 · Women 58% · Also on Medicaid 4% · Health risk score 0.95. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 56% · Diabetes 18% · Coronary heart disease 18% · Cancer 17% · Chronic kidney disease 16% · Depression 13% · Atrial fibrillation 12% · COPD 6% · Heart failure 5% · Dementia 5% · Stroke 5%.
The office billed $289,844, Medicare allowed $96,288 and paid $65,480; for 751 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 319 | 751 | 76 | 0.95 | $289,844 | $65,480 |
| 2023 | 304 | 777 | 76 | 0.84 | $292,468 | $66,463 |
| 2022 | 322 | 782 | 76 | 0.86 | $287,643 | $64,297 |
| 2021 | 300 | 733 | 76 | 0.87 | $271,020 | $61,867 |
| 2020 | 278 | 649 | 76 | 0.88 | $238,762 | $50,393 |
| 2019 | 338 | 866 | 76 | 0.86 | $336,820 | $83,705 |
| 2018 | 351 | 741 | 76 | 0.89 | $160,004 | $69,378 |
| 2017 | 364 | 745 | 76 | 0.89 | $156,120 | $69,713 |
| 2016 | 365 | 727 | 76 | 0.99 | $152,497 | $65,787 |
| 2015 | 368 | 754 | 76 | 0.89 | $156,645 | $69,125 |
| 2014 | 381 | 783 | 76 | 0.88 | $150,433 | $70,649 |
| 2013 | 424 | 926 | 77 | 0.87 | $185,558 | $94,449 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Established patient complete exam of visual system | 256 | $40,267 | $105 |
| Established patient problem focused exam of visual system | 75 | $8,597 | $82 |
| New patient complete exam of visual system | 54 | $6,699 | $124 |
| Exam of visual field with extended testing | 80 | $5,267 | $60 |
| Photography of the retina | 76 | $2,666 | $33 |
| Extended exam of the back part of the eye with retinal drawing | 11 | $300 | $18 |
| Ultrasound scan of cornea to determine thickness | 14 | $93 | $7 |
2022: 6 services
| Established patient complete exam of visual system | 257 | $38,510 | $105 |
| New patient complete exam of visual system | 66 | $8,073 | $122 |
| Established patient problem focused exam of visual system | 60 | $6,479 | $84 |
| Exam of visual field with extended testing | 96 | $5,706 | $56 |
| Photography of the retina | 94 | $3,142 | $31 |
| Ultrasound scan of cornea to determine thickness | 31 | $284 | $9 |
2021: 6 services
| Established patient complete exam of visual system | 252 | $41,423 | $107 |
| Exam of visual field with extended testing | 93 | $5,699 | $58 |
| New patient complete exam of visual system | 45 | $5,438 | $121 |
| Established patient problem focused exam of visual system | 33 | $5,019 | $82 |
| Photography of the retina | 81 | $2,759 | $33 |
| Ultrasound scan of cornea to determine thickness | 30 | $277 | $9 |
2020: 6 services
| Established patient complete exam of visual system | 249 | $33,358 | $96 |
| Established patient problem focused exam of visual system | 34 | $4,744 | $82 |
| Exam of visual field with extended testing | 80 | $4,541 | $54 |
| New patient complete exam of visual system | 31 | $3,225 | $104 |
| Photography of the retina | 70 | $2,696 | $37 |
| Ultrasound scan of cornea to determine thickness | 21 | $172 | $8 |
2019: 9 services
| Established patient complete exam of visual system | 299 | $45,858 | $109 |
| Removal of cataract with insertion of prosthetic lens | 13 | $9,674 | $605 |
| Established patient problem focused exam of visual system | 49 | $8,830 | $85 |
| Exam of visual field with extended testing | 98 | $6,191 | $59 |
| New patient complete exam of visual system | 47 | $5,947 | $127 |
| Photography of the retina | 74 | $3,189 | $42 |
| Ultrasound scan to determine eye length and lens power | 14 | $971 | $57 |
| Imaging of optic nerve | 17 | $481 | $28 |
| Ultrasound scan of cornea to determine thickness | 33 | $335 | $10 |
2018: 8 services
| Established patient complete exam of visual system | 297 | $40,491 | $100 |
| New patient complete exam of visual system | 55 | $6,629 | $121 |
| Established patient problem focused exam of visual system | 35 | $5,491 | $78 |
| Exam of visual field with extended testing | 79 | $4,532 | $53 |
| Photography of the retina | 33 | $1,595 | $47 |
| Imaging of optic nerve | 32 | $917 | $28 |
| Ultrasound scan to determine eye length and lens power | 15 | $542 | $30 |
| Ultrasound scan of cornea to determine thickness | 12 | $157 | $13 |
2017: 5 services
| Established patient complete exam of visual system | 312 | $44,217 | $101 |
| New patient complete exam of visual system | 50 | $6,740 | $135 |
| Established patient problem focused exam of visual system | 31 | $4,354 | $78 |
| Exam of visual field with extended testing | 74 | $3,435 | $41 |
| Imaging of optic nerve | 65 | $2,098 | $30 |
2016: 5 services
| Established patient complete exam of visual system | 316 | $40,457 | $96 |
| Established patient problem focused exam of visual system | 44 | $6,751 | $77 |
| New patient complete exam of visual system | 49 | $5,990 | $122 |
| Exam of visual field with extended testing | 64 | $2,684 | $37 |
| Imaging of optic nerve | 48 | $1,793 | $37 |
2015: 6 services
| Established patient complete exam of visual system | 331 | $46,390 | $100 |
| Established patient problem focused exam of visual system | 51 | $5,736 | $74 |
| New patient complete exam of visual system | 38 | $4,657 | $123 |
| Exam of visual field with extended testing | 69 | $2,878 | $41 |
| Imaging of optic nerve | 59 | $2,343 | $38 |
| Ultrasound scan of cornea to determine thickness | 12 | $155 | $13 |
2014: 5 services
| Established patient complete exam of visual system | 309 | $44,057 | $101 |
| New patient complete exam of visual system | 66 | $8,122 | $123 |
| Established patient problem focused exam of visual system | 61 | $7,518 | $76 |
| Exam of visual field with extended testing | 74 | $3,105 | $39 |
| Imaging of optic nerve | 64 | $2,438 | $38 |
2013: 8 services
| Established patient complete exam of visual system | 219 | $34,515 | $108 |
| New patient complete exam of visual system | 259 | $31,286 | $121 |
| Established patient problem focused exam of visual system | 61 | $8,540 | $84 |
| Exam of visual field with extended testing | 81 | $3,440 | $40 |
| Imaging of optic nerve | 74 | $2,889 | $39 |
| New patient problem focused exam of visual system | 15 | $1,003 | $67 |
| Ultrasound scan to determine eye length and lens power | 11 | $521 | $37 |
| Ultrasound scan of cornea to determine thickness | 20 | $268 | $13 |
Drugs they prescribed that Part D paid
$111,713
Pharmacies billed $111,713 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 722) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
287 generic and 435 brand-name prescriptions · $111,713 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 17 | $21,763 | $1,280 |
| Xiidra | 16 | $15,170 | $948 |
| Rhopressa | 18 | $12,565 | $698 |
| Cyclosporine | 19 | $11,933 | $628 |
| Vyzulta | 23 | $9,786 | $425 |
See all 14 drugs
| Restasis | 17 | $21,763 | $1,280 |
| Xiidra | 16 | $15,170 | $948 |
| Rhopressa | 18 | $12,565 | $698 |
| Cyclosporine | 19 | $11,933 | $628 |
| Vyzulta | 23 | $9,786 | $425 |
| Brimonidine | 41 | $6,604 | $161 |
| Lumigan | 19 | $6,551 | $345 |
| Simbrinza | 22 | $4,857 | $221 |
| Brimonidine Tartrate-Timolol | 12 | $3,949 | $329 |
| Latanoprost | 284 | $3,892 | $14 |
| Brinzolamide | 15 | $3,473 | $232 |
| Timolol Maleate | 111 | $1,831 | $16 |
| Dorzolamide | 30 | $662 | $22 |
| Neomycin-Polymyxin-Dexameth | 16 | $151 | $9 |
Year by year
| 2024 | 722 | 139 | 0% (0) | 60% | $111,713 |
| 2023 | 740 | 151 | 0% (0) | 61% | $111,915 |
| 2022 | 639 | 124 | 0% (0) | 54% | $110,440 |
| 2021 | 710 | 136 | 0% (0) | 61% | $119,533 |
| 2020 | 708 | 146 | 0% (0) | 59% | $98,013 |
| 2019 | 756 | 173 | 0% (0) | 49% | $89,607 |
| 2018 | 617 | 141 | 0% (0) | 56% | $88,076 |
| 2017 | 505 | 111 | 0% (0) | 50% | $72,025 |
| 2016 | 662 | 130 | 0% (0) | 52% | $82,915 |
| 2015 | 636 | 119 | 0% (0) | 63% | $72,939 |
| 2014 | 755 | 142 | 0% (0) | 69% | $66,461 |
| 2013 | 590 | 137 | 0% (0) | 72% | $58,196 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Restasis | 21 | $27,991 | $1,333 |
| Xiidra | 16 | $16,834 | $1,052 |
| Rhopressa | 15 | $12,259 | $817 |
| Vyzulta | 16 | $8,020 | $501 |
| Lumigan | 20 | $7,625 | $381 |
| Brimonidine | 51 | $7,459 | $146 |
| Latanoprost | 295 | $6,456 | $22 |
| Simbrinza | 15 | $4,784 | $319 |
| Brinzolamide | 17 | $4,404 | $259 |
| Brimonidine Tartrate-Timolol | 16 | $3,837 | $240 |
| Timolol Maleate | 126 | $2,052 | $16 |
| Dorzolamide | 28 | $1,525 | $54 |
| Dorzolamide-Timolol | 12 | $295 | $25 |
| Neomycin-Polymyxin-Dexameth | 16 | $266 | $17 |
2022: 11 drugs
| Restasis | 25 | $25,847 | $1,034 |
| Xiidra | 16 | $12,840 | $803 |
| Simbrinza | 35 | $11,228 | $321 |
| Latanoprost | 250 | $9,127 | $37 |
| Vyzulta | 15 | $7,618 | $508 |
| Rhopressa | 11 | $6,674 | $607 |
| Brimonidine | 35 | $3,652 | $104 |
| Timolol Maleate | 96 | $1,598 | $17 |
| Travoprost | 12 | $1,431 | $119 |
| Dorzolamide | 31 | $1,397 | $45 |
| Neomycin-Polymyxin-Dexameth | 21 | $292 | $14 |
2021: 14 drugs
| Restasis | 24 | $26,622 | $1,109 |
| Simbrinza | 54 | $14,116 | $261 |
| Azopt | 23 | $12,047 | $524 |
| Latanoprost | 265 | $8,761 | $33 |
| Restasis Multidose | 11 | $7,092 | $645 |
| Rhopressa | 11 | $6,500 | $591 |
| Vyzulta | 15 | $6,076 | $405 |
| Combigan | 11 | $5,408 | $492 |
| Brimonidine | 43 | $4,739 | $110 |
| Timolol Maleate | 113 | $1,855 | $16 |
| Prednisolone Acetate | 19 | $1,683 | $89 |
| Dorzolamide | 33 | $1,139 | $35 |
| Dorzolamide-Timolol | 17 | $769 | $45 |
| Neomycin-Polymyxin-Dexameth | 13 | $235 | $18 |
2020: 12 drugs
| Restasis | 31 | $23,880 | $770 |
| Azopt | 35 | $16,565 | $473 |
| Rhopressa | 15 | $9,352 | $623 |
| Simbrinza | 36 | $9,061 | $252 |
| Latanoprost | 297 | $6,326 | $21 |
| Brimonidine | 29 | $4,995 | $172 |
| Pazeo | 11 | $2,558 | $233 |
| Olopatadine | 37 | $1,839 | $50 |
| Timolol Maleate | 88 | $1,108 | $13 |
| Dorzolamide-Timolol | 14 | $922 | $66 |
| Dorzolamide | 15 | $633 | $42 |
| Neomycin-Polymyxin-Dexameth | 11 | $206 | $19 |
2019: 19 drugs
| Restasis | 23 | $16,650 | $724 |
| Azopt | 32 | $13,298 | $416 |
| Combigan | 19 | $6,318 | $333 |
| Rhopressa | 11 | $6,313 | $574 |
| Latanoprost | 243 | $5,318 | $22 |
| Simbrinza | 20 | $4,590 | $229 |
| Durezol | 23 | $4,497 | $196 |
| Prolensa | 11 | $3,563 | $324 |
| Pazeo | 16 | $3,408 | $213 |
| Olopatadine | 35 | $2,705 | $77 |
| Prednisolone Acetate | 28 | $2,495 | $89 |
| Brimonidine | 20 | $1,792 | $90 |
| Valacyclovir | 13 | $1,496 | $115 |
| Moxifloxacin | 26 | $1,260 | $48 |
| Timolol Maleate | 91 | $1,098 | $12 |
| Dorzolamide-Timolol | 17 | $978 | $58 |
| Dorzolamide | 26 | $845 | $32 |
| Epinastine | 11 | $729 | $66 |
| Ketorolac Tromethamine | 23 | $599 | $26 |
2018: 15 drugs
| Restasis | 30 | $23,613 | $787 |
| Azopt | 28 | $12,299 | $439 |
| Travatan Z | 16 | $7,773 | $486 |
| Lumigan | 14 | $6,931 | $495 |
| Combigan | 15 | $5,028 | $335 |
| Prednisolone Acetate | 40 | $3,646 | $91 |
| Brimonidine | 26 | $3,471 | $133 |
| Latanoprost | 144 | $3,138 | $22 |
| Olopatadine | 38 | $2,546 | $67 |
| Moxifloxacin | 35 | $1,501 | $43 |
| Timolol Maleate | 73 | $916 | $13 |
| Dorzolamide | 28 | $778 | $28 |
| Dorzolamide-Timolol | 13 | $564 | $43 |
| Ketorolac Tromethamine | 19 | $338 | $18 |
| Neomycin-Polymyxin-Dexameth | 11 | $143 | $13 |
2017: 16 drugs
| Restasis | 14 | $12,726 | $909 |
| Azopt | 26 | $10,830 | $417 |
| Lumigan | 16 | $6,358 | $397 |
| Combigan | 22 | $5,435 | $247 |
| Travatan Z | 15 | $4,645 | $310 |
| Alphagan P | 11 | $4,428 | $403 |
| Brimonidine | 30 | $3,484 | $116 |
| Latanoprost | 129 | $2,879 | $22 |
| Vigamox | 13 | $2,111 | $162 |
| Durezol | 11 | $1,830 | $166 |
| Simbrinza | 12 | $1,682 | $140 |
| Olopatadine | 28 | $1,459 | $52 |
| Prednisolone Acetate | 13 | $1,261 | $97 |
| Dorzolamide-Timolol | 20 | $1,138 | $57 |
| Timolol Maleate | 52 | $545 | $10 |
| Neomycin-Polymyxin-Dexameth | 16 | $228 | $14 |
2016: 15 drugs
| Azopt | 25 | $10,398 | $416 |
| Lumigan | 28 | $9,818 | $351 |
| Alphagan P | 18 | $8,386 | $466 |
| Brimonidine | 48 | $8,187 | $171 |
| Combigan | 22 | $5,166 | $235 |
| Latanoprost | 171 | $4,190 | $25 |
| Pataday | 24 | $4,172 | $174 |
| Travatan Z | 14 | $3,429 | $245 |
| Vigamox | 17 | $2,591 | $152 |
| Durezol | 16 | $2,495 | $156 |
| Prednisolone Acetate | 23 | $2,208 | $96 |
| Dorzolamide-Timolol | 29 | $1,370 | $47 |
| Timolol Maleate | 76 | $703 | $9 |
| Dorzolamide | 14 | $309 | $22 |
| Neomycin-Polymyxin-Dexameth | 12 | $191 | $16 |
2015: 14 drugs
| Azopt | 27 | $9,853 | $365 |
| Brimonidine | 50 | $8,758 | $175 |
| Lumigan | 30 | $8,744 | $291 |
| Restasis | 11 | $8,234 | $749 |
| Travatan Z | 18 | $5,078 | $282 |
| Alphagan P | 12 | $5,016 | $418 |
| Combigan | 28 | $4,711 | $168 |
| Zioptan | 15 | $3,733 | $249 |
| Latanoprost | 196 | $3,218 | $16 |
| Timolol Maleate | 86 | $2,540 | $30 |
| Pataday | 14 | $2,358 | $168 |
| Prednisolone Acetate | 23 | $2,127 | $92 |
| Dorzolamide-Timolol | 28 | $1,234 | $44 |
| Neomycin-Polymyxin-Dexameth | 14 | $224 | $16 |
2014: 17 drugs
| Azopt | 39 | $7,571 | $194 |
| Restasis | 12 | $7,505 | $625 |
| Brimonidine | 42 | $6,562 | $156 |
| Lumigan | 27 | $5,948 | $220 |
| Travatan Z | 25 | $5,440 | $218 |
| Latanoprost | 232 | $4,614 | $20 |
| Combigan | 31 | $4,501 | $145 |
| Alphagan P | 15 | $3,865 | $258 |
| Pataday | 20 | $3,360 | $168 |
| Zioptan | 22 | $2,760 | $125 |
| Prednisolone Acetate | 27 | $2,700 | $100 |
| Timolol Maleate | 95 | $2,122 | $22 |
| Dorzolamide-Timolol | 39 | $2,027 | $52 |
| Vigamox | 13 | $1,443 | $111 |
| Dorzolamide | 21 | $389 | $19 |
| Neomycin-Polymyxin-Dexameth | 19 | $343 | $18 |
| Erythromycin | 11 | $183 | $17 |
2013: 16 drugs
| Travatan Z | 32 | $6,664 | $208 |
| Restasis | 13 | $6,052 | $466 |
| Azopt | 39 | $5,917 | $152 |
| Alphagan P | 25 | $5,851 | $234 |
| Lumigan | 31 | $5,486 | $177 |
| Brimonidine | 36 | $4,246 | $118 |
| Nevanac | 23 | $3,728 | $162 |
| Pataday | 17 | $2,789 | $164 |
| Latanoprost | 123 | $2,733 | $22 |
| Combigan | 14 | $2,380 | $170 |
| Vigamox | 19 | $1,909 | $100 |
| Timolol Maleate | 56 | $1,531 | $27 |
| Dorzolamide-Timolol | 25 | $1,494 | $60 |
| Prednisolone Acetate | 29 | $866 | $30 |
| Dorzolamide | 22 | $729 | $33 |
| Neomycin-Polymyxin-Dexameth | 27 | $487 | $18 |
Money from drug and device companies
$126 in 2025
| 2025 | 3 | 5 | None | $126 |
| 2024 | 2 | 2 | None | $150 |
| 2023 | 1 | 3 | None | $75 |
| 2022 | 1 | 1 | None | $29 |
| 2021 | 2 | 3 | None | $68 |
| 2019 | 2 | 2 | None | $73 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Rocklatan | $55 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $51 | 2 payments
|
| Bausch & Lomb Americas | Vyzulta | $20 | 1 payment
|
See all 5 published payments
| Oyster Point Pharma | Meals · 2025-10-27 | Ryzumvi | $25 |
| Bausch & Lomb Americas | Meals · 2025-10-15 | Vyzulta | $20 |
| Alcon Vision | Meals · 2025-10-01 | Rocklatan | $31 |
| Alcon Vision | Meals · 2025-05-31 | Rocklatan | $24 |
| Oyster Point Pharma | Meals · 2025-02-20 | Tyrvaya | $27 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $150
| Oyster Point Pharma | Tyrvaya | $118 | 1 payment
|
| Astellas Pharma US | Izervay | $32 | 1 payment
|
2023: $75
| Oyster Point Pharma | Tyrvaya | $75 | 3 payments
|
2022: $29
| BioTissue Holdings | Prokera | $29 | 1 payment
|
2021: $68
| Tissuetech | Prokera | $50 | 2 payments
|
| Aerie Pharmaceuticals | Rhopressa | $19 | 1 payment
|
2019: $73
| TissueTech | Prokera | $56 | 1 payment
|
| Alcon Vision | Lensx | $17 | 1 payment
|
Professional record
- NPI
- 1598843963
- Licence
- CA G839841
- Trained
- University of California, San Francisco School of Medicine, 1993 · 33 years ago
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G839841
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 3838 California St, Rm 100, San Francisco, CA, 94118
- NPI first listed
- 2006-11-01
- NPI last updated
- 2017-10-26
This is when the NPI record was last certified, not a medical board exam.